Financial Data and Key Metrics Changes - Total company revenue for Q4 2025 was $539.1 million, a 15.9% increase from $465 million in Q4 2024 [8] - For the full year 2025, revenue reached $2.2 billion, up 13.9% from $1.9 billion in 2024 [9] - Adjusted EBITDA for Q4 2025 was $95.3 million, a 22.9% increase from $77.5 million in Q4 2024 [14] - Adjusted net income attributable to the company was $36.1 million for Q4 2025, compared to $22.2 million in the prior year [16] Business Line Data and Key Metrics Changes - Occupational health center segment revenue was $490.6 million in Q4 2025, a 12.2% increase year-over-year [19] - On-site health clinics segment reported revenue of $36.2 million in Q4 2025, a 112% increase from the same quarter prior year, largely due to the acquisition of Pivot [22] - Other businesses generated revenue of $12.3 million in Q4 2025, a 12.6% increase year-over-year [23] Market Data and Key Metrics Changes - Total patient visits increased 9% to over 51,000 visits per day in Q4 2025 [9] - Workers' compensation visits per day increased 9.1%, while employer service visits increased 9.4% compared to the prior year [10] - The blue-collar economy added over 450,000 net jobs in 2025, growing at a rate of 0.4% [12] Company Strategy and Development Direction - The company plans to continue with smaller bolt-on acquisitions, which are expected to be accretive due to top line and cost synergies [18] - A strong pipeline for de novo openings is anticipated, with targets of 7 to 9 new sites in 2026 [33] - The company is actively monitoring the New York workers' compensation fee schedule for potential expansion opportunities [34] Management's Comments on Operating Environment and Future Outlook - Management remains positive on the long-term outlook for the U.S. labor market, expecting to add 5.2 million jobs from 2024 through 2034 [12] - The company anticipates stable injury incidence rates and an aging workforce will provide strong tailwinds for business growth [13] - Management expressed confidence in achieving the 2026 revenue target of $2.25 billion to $2.35 billion [36] Other Important Information - The company generated $118.7 million in operating cash flow in Q4 2025, an increase from $93.7 million in Q4 2024 [27] - Free Cash Flow for the full year was $197.8 million, with a conversion rate of 114% [29] - A cash dividend of six and a quarter cents per share was declared, payable on March 19, 2026 [39] Q&A Session Summary Question: How are you contemplating weather or potential elevated respiratory activity to start the year? - Management does not anticipate significant impacts from weather or respiratory activity on operations [42][43] Question: Can you walk us through your thought process on evaluating new opportunities for de novos or M&A? - The company closely monitors Return on Invested Capital and has a track record of successful M&A and de novo execution [44][45] Question: Can you provide more detail about the New York opportunity and how quickly you could enter the market? - Management is looking for a comprehensive review of the fee schedule and believes they can move quickly to establish new centers if conditions improve [49][50][53] Question: What is the expected cadence for 2026 and how will de novo investments be spread throughout the year? - The company expects to have a pickup in Q1 from recent acquisitions and plans to spread de novo openings throughout the year [56][58] Question: How is labor retention trending and what type of wage inflation is built into the guide? - Labor trends are normal with wage inflation in the 2%-3% range, and turnover is decreasing, indicating a more stable workforce [66][68] Question: Who are you taking market share from and is this sustainable growth? - The company has developed technologies to capture additional customers and improve retention, supporting sustainable growth [71][72][74]

Concentra Group Holdings Parent (NYSE:CON) Q4 2025 Earnings call February 27, 2026 09:00 AM ET Company ParticipantsKeith Newton - Chairman and CEOMatthew DiCanio - EVP, CFO and TreasurerConference Call ParticipantsAnn Hynes - Md and Senior Equity Research AnalystBen Hendrix - VP and Equity Research AnalystBenjamin Rossi - Healthcare Facilities AnalystChristopher Mitchell - AnalystJoanna Gajuk - Equity Research AnalystJustin Bowers - Equity Research AnalystOperatorGood morning, thank you for joining us today ...

Financial Data and Key Metrics Changes - Total company revenue for Q4 2025 was $539.1 million, a 15.9% increase from $465 million in Q4 2024 [6] - For the full year 2025, revenue reached $2.2 billion, up 13.9% from $1.9 billion in 2024 [7] - Adjusted EBITDA for Q4 2025 was $95.3 million, a 22.9% increase from $77.5 million in Q4 2024 [12] - Adjusted net income attributable to the company was $36.1 million for Q4 2025, compared to $22.2 million in the prior year [15] Business Line Data and Key Metrics Changes - Occupational health center segment revenue was $490.6 million in Q4 2025, a 12.2% increase year-over-year [18] - Workers' compensation revenue in Q4 2025 was $328.5 million, up 13.6% from the prior year [19] - On-site health clinics segment reported revenue of $36.2 million in Q4 2025, a 112% increase year-over-year, largely due to the acquisition of Pivot [21] Market Data and Key Metrics Changes - Total patient visits increased 9% to over 51,000 visits per day in Q4 2025 [7] - Workers' compensation visits per day increased 9.1%, while employer service visits increased 9.4% compared to the prior year [8] - The U.S. labor market grew at a rate of 0.1% in 2025, but the blue-collar economy added over 450,000 net jobs, growing at 0.4% [10] Company Strategy and Development Direction - The company plans to continue with smaller bolt-on acquisitions, which are expected to be highly accretive due to top-line and cost synergies [17] - The company is targeting 7 to 9 de novo openings in 2026, which would be a record for the company [32] - The company is actively monitoring the New York workers' compensation fee schedule for potential opportunities to expand into the state [33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term outlook for the U.S. labor market, expecting to add 5.2 million jobs from 2024 through 2034 [10] - The company anticipates steady growth in revenue per visit and visits, with a focus on maintaining efficiency gains captured in 2025 [36] - Management noted that they are largely through the integration process for the Nova and Pivot acquisitions and have captured most expected synergies [32] Other Important Information - The company generated $118.7 million in operating cash flow in Q4 2025, compared to $93.7 million in Q4 2024 [27] - Free Cash Flow for the full year was $197.8 million, with a conversion rate of 114% [29] - The company declared a cash dividend of $0.0625 per share, payable on March 19, 2026 [37] Q&A Session Summary Question: How are you contemplating impacts from weather or potential elevated respiratory activity? - Management indicated that weather has not significantly impacted operations and does not anticipate material effects from respiratory activity [42] Question: Can you elaborate on your Return on Invested Capital assessment for new opportunities? - Management stated they closely monitor ROIC and have a track record of successful M&A and de novo execution, typically resulting in strong ROICs [44] Question: What are your expectations regarding the New York opportunity? - Management highlighted the need for a comprehensive look at the fee schedule and expressed readiness to move quickly into the market once conditions improve [51] Question: How do you view the 2026 outlook in terms of seasonality and de novo investments? - Management confirmed that they expect a pickup in Q1 from recent acquisitions and are working on spreading de novo openings throughout the year [58] Question: What is the impact of the Select services agreement expiration on margins? - Management noted that they are nearing completion of the hiring process and expect TSA costs to ramp down by mid-2026, which will have some impact on margins [62] Question: How is labor retention trending and what wage inflation is built into the guide? - Management reported normal wage inflation trends of 2%-3% and noted improvements in retention and reduced turnover [67][68]

4th Quarter 2025 Results February 26, 2026 ©2026 Concentra Inc. All rights reserved. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express Concentra Group Holdings Parent, Inc.'s ("Concentra," the "Company," "we" or "our") current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to, financial guidance and other projections and forecasts. Forward looking ...

Concentra Group (CON) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +21.74%. A quarter ago, it was expected that this provider of occupational health services would post earnings of $0.37 per share when it actually produced earnings of $0.39, delivering a surprise of +5.41%.Over the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbers: 001-42188 CONCENTRA GROUP HOLDINGS PARENT, INC. (Exact name of Registrant as specified in its Charter) Delaware 30-1006613 (State or Other Jurisdictio ...

Core Viewpoint - Consolidated Edison, Inc. reported a strong financial performance for 2025, with net income increasing to $2,023 million or $5.66 per share, up from $1,820 million or $5.26 per share in 2024, reflecting the resilience of its regulated businesses and strategic investments [1][2]. Financial Performance - For 2025, adjusted earnings were $2,038 million or $5.70 per share, compared to $1,868 million or $5.40 per share in 2024, excluding certain impairment losses and transaction costs [1][2]. - In Q4 2025, net income was $297 million or $0.82 per share, down from $310 million or $0.90 per share in Q4 2024, while adjusted earnings were $320 million or $0.89 per share, compared to $340 million or $0.98 per share in the same period [1][2]. Strategic Investments and Future Outlook - The company plans to invest $6,595 million in 2026 and $6,759 million in 2027, with a total of $24,339 million expected from 2028 to 2030, funded through internal resources and long-term debt issuance [1][2]. - Con Edison anticipates a compounded annual growth rate of 6% to 7% for adjusted earnings per share over the next five years, with 2026 adjusted EPS guidance set between $6.00 and $6.20 [1][2]. Operational Highlights - The company emphasized the importance of maintaining cost discipline while investing in critical projects to support the clean energy transition and regional growth [1][2]. - Con Edison has increased its dividend for the 52nd consecutive year, reflecting its commitment to delivering value to shareholders [1][2]. Revenue and Expenses - Total operating revenues for 2025 were $16,918 million, up from $15,256 million in 2024, driven by higher electric and gas sales [3][4]. - Operating expenses increased to $13,987 million in 2025 from $12,524 million in 2024, primarily due to higher costs in purchased power and maintenance [3][4].

Core Insights - Concentra is emerging as a dominant player in its segment of the healthcare industry, showcasing a unique structural advantage that supports consistent growth [1] Company Analysis - Concentra's growth potential is attributed to its strong brand recognition and solid financials, positioning it favorably within the healthcare sector [1] Industry Trends - The healthcare industry is witnessing shifts that favor companies like Concentra, which are able to leverage their structural advantages for sustained growth [1]

Financial Reporting - Concentra Group Holdings Parent, Inc. will present preliminary, unaudited operational metrics for Q4 2025 on January 14, 2026[4] - The presentation will be available on the Company's investor relations website after the event[4] - The Company is not classified as an emerging growth company under the Securities Act[3] Forward-Looking Statements - Forward-looking statements regarding future expectations and plans are included, with actual results potentially differing due to various factors[6] - The Company disclaims any obligation to update forward-looking statements except as required by law[6]

Core Insights - Concentra Group Holdings Parent, Inc. reported preliminary unaudited financial results for Q4 and full year 2025, exceeding previous guidance for the year [1][2] - The company anticipates continued growth in 2026, supported by strong performance in 2025 and a detailed business outlook [5][9] Financial Performance - For Q4 2025, Concentra expects to report revenue of $539.1 million, a 15.9% increase from Q4 2024's $465.0 million [5] - Net income for Q4 2025 is projected at $36.2 million, up 58.7% from $22.8 million in Q4 2024 [5] - Adjusted EBITDA for Q4 2025 is expected to be $95.3 million, reflecting a 22.9% increase from $77.5 million in Q4 2024 [5] - Full year 2025 revenue is anticipated to be $2,163.4 million, a 13.9% increase from $1,900.2 million in FY 2024 [5] Operational Metrics - Total patient visits for Q4 2025 reached 3,264,322, a 9.0% increase from 2,994,988 in Q4 2024 [29] - The average revenue per visit in Q4 2025 was $149.63, up 3.1% from $145.08 in Q4 2024 [29] - For the full year 2025, total patient visits were 13,546,707, a 7.3% increase from 12,623,503 in FY 2024 [32] Business Outlook - For 2026, Concentra expects revenue in the range of $2.25 billion to $2.35 billion, with Adjusted EBITDA between $450 million and $470 million [12][35] - The company aims to maintain a net leverage ratio of 3.0x or below and anticipates free cash flow of $200 million to $225 million [12][35] Company Overview - Concentra is the largest provider of occupational health services in the U.S. by number of locations, operating 628 occupational health centers and 411 onsite health clinics [10] - The company supports approximately 53,000 patients daily across 47 states, focusing on improving the health of America's workforce [10]